
Liquidity, historical trends, and peer comparisons.
According to Clene Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.07. This represents a change of 66.88% compared to the average of 1.84 of the last 4 quarters.
The mean historical Current Ratio of Clene Inc. over the last ten years is 2.92. The current 3.07 Current Ratio has changed 5.37% with respect to the historical average. Over the past ten years (40 quarters), CLNN's Current Ratio was at its highest in in the June 2021 quarter at 15.08. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
2.92
Median
2.11
Minimum
0
Maximum
9.06
Discovering the peaks and valleys of Clene Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 9.06
Minimum Annual Increase = -76.74%
Minimum Annual Current Ratio = 0
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 0.83 | -46.94% |
| 2024 | 1.57 | 2.36% |
| 2023 | 1.53 | -27.20% |
| 2022 | 2.11 | -76.74% |
| 2021 | 9.06 | 67.79% |
| 2020 | 5.40 | 145.74% |
| 2019 | 2.20 | -38.24% |
| 2018 | 3.56 | Infinity% |
The current Current Ratio of Clene Inc. (CLNN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.31
5-year avg
3.02
10-year avg
2.92
Clene Inc.’s Current Ratio is greater than MacroGenics, Inc. (2.96), less than Ovid Therapeutics Inc. (12.39), less than Coya Therapeutics, Inc. (13.40), less than Oramed Pharmaceuticals Inc. (4.98), less than Whitehawk Therapeutics Inc (17.38), less than Context Therapeutics Inc. (5.81), less than Zentalis Pharmaceuticals, Inc. (4.82), less than Shattuck Labs, Inc. (27.59), less than Pliant Therapeutics, Inc. (9.90), greater than Connect Biopharma Holdings Limited (2.37),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.96 | $158.93M | |
| 12.39 | $485.32M | |
| 13.40 | $79.75M | |
| 4.98 | $168.89M | |
| 17.38 | $180.15M | |
| 5.81 | $18.09M | |
| 4.82 | $135.61M | |
| 27.59 | $535.94M | |
| 9.90 | $52.27M | |
| 2.37 | $49.75M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clene Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Clene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Clene Inc.'s Current Ratio?
How is the Current Ratio calculated for Clene Inc. (CLNN)?
What is the highest Current Ratio for Clene Inc. (CLNN)?
What is the 3-year average Current Ratio for Clene Inc. (CLNN)?
What is the 5-year average Current Ratio for Clene Inc. (CLNN)?
How does the current Current Ratio for Clene Inc. (CLNN) compare to its historical average?